Literature DB >> 35614899

Confounding by Indication Is a Major Issue in the Available Evidence on Role of Portal Vein Resection in Patients Undergoing Curative Surgery for Klatskin Tumour.

Shahab Hajibandeh1, Shahin Hajibandeh2, Karim Hassan1, Sumera Baloch1, Thomas Satyadas3.   

Abstract

Entities:  

Year:  2021        PMID: 35614899      PMCID: PMC9082134          DOI: 10.1159/000517690

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


× No keyword cloud information.
  12 in total

1.  The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.

Authors:  Mechteld C de Jong; Hugo Marques; Bryan M Clary; Todd W Bauer; J Wallis Marsh; Dario Ribero; Pietro Majno; Ioannis Hatzaras; Dustin M Walters; Andrew S Barbas; Raquel Mega; Richard D Schulick; Michael A Choti; David A Geller; Eduardo Barroso; Gilles Mentha; Lorenzo Capussotti; Timothy M Pawlik
Journal:  Cancer       Date:  2012-03-13       Impact factor: 6.860

Review 2.  Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection.

Authors:  Masaru Miyazaki; Fumio Kimura; Hiroaki Shimizu; Hiroyuki Yoshidome; Masayuki Ohtsuka; Atsushi Kato; Hideyuki Yoshitomi; Satoshi Nozawa; Katsunori Furukawa; Noboru Mitsuhashi; Dan Takeuchi; Kousuke Suda; Isaku Yoshioka
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-09-28

3.  Portal vein resection for hilar cholangiocarcinoma.

Authors:  Alan W Hemming; Robin D Kim; Kristin L Mekeel; Shiro Fujita; Alan I Reed; David P Foley; Richard J Howard
Journal:  Am Surg       Date:  2006-07       Impact factor: 0.688

Review 4.  Combined portal vein resection in the treatment of hilar cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  W Chen; K Ke; Y L Chen
Journal:  Eur J Surg Oncol       Date:  2014-02-28       Impact factor: 4.424

Review 5.  Cholangiocarcinoma.

Authors:  Shahid A Khan; Howard C Thomas; Brian R Davidson; Simon D Taylor-Robinson
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

6.  Combined portal vein resection for hilar cholangiocarcinoma: a meta-analysis of comparative studies.

Authors:  Xiang-Song Wu; Ping Dong; Jun Gu; Mao-Lan Li; Wen-Guang Wu; Jian-Hua Lu; Jia-Sheng Mu; Qi-Chen Ding; Lin Zhang; Qian Ding; Hao Weng; Ying-Bin Liu
Journal:  J Gastrointest Surg       Date:  2013-04-17       Impact factor: 3.452

7.  Hepatic resection combined with portal vein or hepatic artery reconstruction for advanced carcinoma of the hilar bile duct and gallbladder.

Authors:  Hiroshi Shimada; Itaru Endo; Mitsutaka Sugita; Hideki Masunari; Yoshiro Fujii; Kuniya Tanaka; Koichi Misuta; Hitoshi Sekido; Shinji Togo
Journal:  World J Surg       Date:  2003-08-21       Impact factor: 3.352

Review 8.  Surgical Approach to Recurrent Cholangiocarcinoma.

Authors:  Hauke Lang
Journal:  Visc Med       Date:  2020-12-21

9.  Improving Outcomes in Perihilar Cholangiocarcinoma.

Authors:  Karl J Oldhafer; Thomas von Hahn; Marianna Arvanitakis; Masato Nagino; Orlando J M Torres
Journal:  Visc Med       Date:  2021-01-06

Review 10.  Surgical Therapy for Perihilar Cholangiocarcinoma: State of the Art.

Authors:  Lynn E Nooijen; Rutger-Jan Swijnenburg; Heinz-Josef Klümpen; Joanne Verheij; Geert Kazemier; Thomas M van Gulik; Joris I Erdmann
Journal:  Visc Med       Date:  2021-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.